Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT01837420
What this trial is testing

Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Who this might be right for
Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 194
Testing effectiveness (Phase 2)Looking for participantsNCT06592274
What this trial is testing

HB0017 in Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
Huabo Biopharm Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT05509361
What this trial is testing

Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 950
Post-approval studies (Phase 4)Study completedNCT05478499
What this trial is testing

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 154
Testing effectiveness (Phase 2)Study completedNCT02054481
What this trial is testing

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab

Who this might be right for
Psoriasis
Boehringer Ingelheim 166
Large-scale testing (Phase 3)Study completedNCT03168256
What this trial is testing

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 528
Not applicableLooking for participantsNCT06987292
What this trial is testing

A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

Who this might be right for
Psoriasis (PsO)EnthesitisPsoriasis Arthritis+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)UnknownNCT04839016
What this trial is testing

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 660
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Large-scale testing (Phase 3)Study completedNCT06588283
What this trial is testing

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Who this might be right for
PsoriasisObesity
Eli Lilly and Company 281
Early research (Phase 1)Study completedNCT01488201
What this trial is testing

A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07719530
What this trial is testing

Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis

Who this might be right for
Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Post-approval studies (Phase 4)Ended earlyNCT04339595
What this trial is testing

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 47
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Not applicableLooking for participantsNCT07746583
What this trial is testing

Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

Who this might be right for
Psoriasis
Janssen-Cilag Kft. 100
Testing effectiveness (Phase 2)Study completedNCT04776629
What this trial is testing

A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

Who this might be right for
PsoriasisInflammationCoronary Artery Disease+1 more
Abcentra 77
Not applicableUnknownNCT03817164
What this trial is testing

Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Thync Global, Inc. 110
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Next Page